Andrew Phillips, Ph.D.
Andy Phillips is the director of the Center for the Development of Therapeutics at Broad Institute of MIT and Harvard. Phillips began his career by establishing himself as a world-class synthetic chemist. He has developed novel methods and strategies for the construction of complex molecules and has applied these ideas to the total chemical synthesis of some of the most complex natural products known. Phillips then transitioned his research focus from synthetic chemistry towards developing new technologies for ligand discovery and identifying therapeutic leads that modulate otherwise intractable disease targets. He also brings to the Broad Institute expertise in NMR spectroscopy and ion-mobility mass spectrometry.
Phillips completed a B. Sc. (Hons) and Ph. D. in biochemistry at the University of Canterbury in New Zealand. After a postdoctoral position with Peter Wipf in Pittsburgh, he joined the faculty at the University of Colorado in the Fall of 2001. Immediately prior to joining the Broad Institute, he was a Full Professor of Chemistry at Yale University. During the spring semester of 2009 he was a visiting faculty member in the Department of Chemistry and Chemical Biology at Harvard University and at the Broad Institute.
His research has been recognized by a number of awards, including an ACS Cope Scholar Award, an Eli Lilly Grantee Award, an NSF Career Award, and an Alfred P. Sloan Research Fellowship.